Profil
Jack Tsai worked as Vice President-Business Development at Inhibrx, Inc. from 2021 to 2022.
He completed his undergraduate degree at the University of Rochester, followed by an MBA from MIT Sloan School of Management.
He also holds a doctorate degree from Tufts University School of Medicine.
Ehemalige bekannte Positionen von Jack Tsai
Unternehmen | Position | Ende |
---|---|---|
INHIBRX, INC. | Corporate Officer/Principal | 01.09.2022 |
Ausbildung von Jack Tsai
MIT Sloan School of Management | Masters Business Admin |
Rochester Christian University | Undergraduate Degree |
Tufts University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Inhibrx, Inc.
Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |